Skip to content

INFINITT North America expands its collaboration with Concert AI’s TeraRecon

August 6, 2023 – INFINITT North America recently announced the expansion of its collaboration with Concert AI’s TeraRecon, joining forces to deliver solutions on the Eureka Clinical AI Platform – the innovative AI SaaS solution in medical imaging interpretation and clinical decision support.

Eureka Clinical AI Platform stands out for its compatibility with third-party AI algorithms, enabling unified management of all AI interpretation applications and smooth integration with PACS or EMR systems. This allows multi-specialty care teams to effortlessly view results, receive crucial mobile alerts, and validate AI findings, ultimately improving patient outcomes and delivering coordinated care.

Dan McSweeney, President of TeraRecon, emphasized that an outstanding AI ecosystem relies on four essential components. “Firstly, it must accommodate all forms of AI, including customer-developed, TeraRecon-developed, and third-party algorithms. Secondly, it must prioritize physician-centricity by empowering clinicians and reinforcing their role in decision-making and diagnosis. Thirdly, integration is key: the AI platform needs to serve as a single access point for consolidating solutions while minimizing the procurement burden for new algorithms and standardizing deployment processes. And finally, transparency in AI performance must be maintained to build trust in its application.” These elements need to rest on a vendor-neutral platform that is scalable, secure, and robust.

INFINITT recognizes that AI software can significantly benefit radiology and enterprise imaging across multiple aspects. It has proven its capabilities in enhancing reading workflows, pinpointing critical regions of interest, and highlighting potential abnormalities for doctors’ review.

At INFINITT, we are committed to actively collaborating with third-party AI algorithm firms, so their software integrates flawlessly into the end-user workflow. Our departmental and enterprise PACS solutions have been explicitly designed to communicate with both on-premises and cloud-based AI platforms and algorithms.

In addition to the Eureka Clinical AI Platform INFINITT Cardiology PACS integrates with TeraRecon’s Intuition®.  Their recent release Intuition 4.7 brings a  simplified approach to structural heart workflows, complex cardiac analysis and quantification, enabling a radiologist or cardiologist to analyze coronary vessels with zero-click centerline creation and extraction. Vascular evaluation tools include plaque and soft plaque, stenosis, curvature, tortuosity, and more.

In times of scarcity in the medical professional world, AI-powered tools that enhance physician productivity are indispensable assets. Dave Smarro, INFINITT’s CEO says, “Integrating our solutions with the power of AI not only reduces errors and workloads, but it also gives the industry opportunity to invest in the highest level of care.”  To discover how the INFINITT TeraRecon partnership can equip your medical facility with early detection and diagnosis in medical imaging, visit

About TeraRecon: Serving ~1,900 clinical sites globally, TeraRecon, a ConcertAI company, is a Best in KLAS solution provider for AI-empowered radiology, oncology, cardiology, neurology, and vascular surgery. Awarded the KLAS Category Leader for Advanced Visualization, TeraRecon solutions are independent of any one manufacturer’s imaging equipment or PACS, allowing a single, unified, and simplified clinical workflow that can improve efficiencies and deliver actionable physician-guided insights. For more information, visit us at